SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 100 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $64,837,000 | -34.2% | 7,746,382 | -28.8% | 0.01% | -36.4% |
Q3 2019 | $98,491,000 | -17.2% | 10,883,082 | -1.4% | 0.02% | -15.4% |
Q2 2019 | $118,901,000 | +188.9% | 11,039,985 | +155.9% | 0.03% | +188.9% |
Q1 2019 | $41,150,000 | +75.0% | 4,313,453 | +110.5% | 0.01% | +50.0% |
Q4 2018 | $23,520,000 | +18.7% | 2,048,725 | +75.2% | 0.01% | +50.0% |
Q3 2018 | $19,817,000 | +814.5% | 1,169,218 | +666.3% | 0.00% | – |
Q2 2018 | $2,167,000 | -35.2% | 152,574 | -13.3% | 0.00% | -100.0% |
Q1 2018 | $3,344,000 | +53.9% | 176,017 | +32.8% | 0.00% | – |
Q4 2017 | $2,173,000 | +339.0% | 132,502 | +55.0% | 0.00% | – |
Q2 2016 | $495,000 | -37.4% | 85,500 | -34.6% | 0.00% | – |
Q1 2016 | $791,000 | -66.1% | 130,700 | -68.4% | 0.00% | -100.0% |
Q3 2015 | $2,334,000 | -48.9% | 413,720 | +0.5% | 0.00% | 0.0% |
Q2 2015 | $4,565,000 | -28.1% | 411,580 | +1.6% | 0.00% | -50.0% |
Q1 2015 | $6,351,000 | +5.6% | 405,040 | +2.4% | 0.00% | 0.0% |
Q4 2014 | $6,014,000 | +24.4% | 395,380 | -11.8% | 0.00% | +100.0% |
Q3 2014 | $4,836,000 | -21.8% | 448,480 | +10.7% | 0.00% | -50.0% |
Q2 2014 | $6,186,000 | +1067.2% | 405,120 | +497.5% | 0.00% | – |
Q2 2013 | $530,000 | – | 67,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |